$IBB Recent News S&P clears the 2,000 mark, reaches

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2014 at 11:17 AM

$IBB Recent News

S&P clears the 2,000 mark, reaches uncharted territory 11:49 a.m. Aug. 26, 2014 - Michael Ashbaugh
S&P clears the 2,000 mark, reaches uncharted territory 11:35 a.m. Aug. 26, 2014 - Michael Ashbaugh
This one stock sector can withstand all the ‘bubble’ talk 6:01 a.m. Aug. 21, 2014 - Jeff Reeves
S&P 500 retests the breakdown point 11:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
U.S. stocks push higher; biotechs rally 4:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Dow, S&P 500 inch up, while Nasdaq, Russell 2000 slip: stock market live blog recap 3:34 p.m. July 28, 2014 - blogs.marketwatch.com
Momentum plays stabilize: Biotech, social-media stocks rally in the past week 5:52 p.m. July 25, 2014 - blogs.marketwatch.com
Stocks bounce back Friday, end with gains for the week: live blog recap 3:21 p.m. July 18, 2014 - blogs.marketwatch.com
Another bear market for froth stocks? 3:03 p.m. July 17, 2014 - John Nyaradi
U.S. stocks gain; Dow sets its 15th record of the year 4:03 p.m. July 16, 2014 - Anora Mahmudova
U.S. stocks close lower; Dow ekes out a gain 4:17 p.m. July 15, 2014 - Anora Mahmudova
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Social-media and biotech stocks weaker after Fed warning 10:23 a.m. July 15, 2014 - Steve Goldstein
U.S. stocks fall; momentum plays hit hard 4:21 p.m. July 8, 2014 - Anora Mahmudova
Dow falls by triple digits, closes back under 17,000: stock market live blog recap 3:51 p.m. July 8, 2014 - blogs.marketwatch.com
Momentum mauled: Biotech, Facebook, Twitter hit hard 12:32 p.m. July 8, 2014 - blogs.marketwatch.com
S&P 500, Dow Industrials log first losses in July: live blog recap 4:12 p.m. July 7, 2014 - blogs.marketwatch.com
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
S&P 500 closes at record after shaking off early loss: stock market live blog recap 3:45 p.m. June 4, 2014 - blogs.marketwatch.com
Stocks could fall 15% to 20% as 'QE fluff' comes out of the market 3:00 p.m. May 29, 2014 - blogs.marketwatch.com

Momentum Investing: Big Risk, Rare Reward 6:15 a.m. Today - Barrons.com
Investigate Before You Invest in Gold 9:16 p.m. Sept. 1, 2014 - InvestorPlace.com
Today's Market: Red Hot Biotech And Big Pharma Names To Watch 8:22 a.m. Aug. 29, 2014 - Seeking Alpha
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Isis Pharmaceuticals Finally Breaks Out 11:30 a.m. Aug. 27, 2014 - benzinga.com
After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary 8:00 a.m. Aug. 27, 2014 - Zacks.com
Get a Jump-Start on Your Portfolio Cleaning 9:11 p.m. Aug. 26, 2014 - InvestorPlace.com
Kick the Dogs Out of Your Portfolio Now! 9:03 p.m. Aug. 25, 2014 - InvestorPlace.com
Economic Recovery Doesn't Satisfy Fed as Stocks Soar Higher 11:14 a.m. Aug. 21, 2014 - TheStreet.com
Like I said, we're almost free of Ebola 12:25 p.m. Aug. 20, 2014 - Seeking Alpha
Sell Overpriced Bonds While You Still Have the Chance 9:03 p.m. Aug. 18, 2014 - InvestorPlace.com
Nasdaq Composite: What Are You Buying That's Driving New Highs? - Real Time Insight 2:04 p.m. Aug. 18, 2014 - Zacks.com
Large Number of Sell Signals Should Give Traders Pause 9:44 p.m. Aug. 17, 2014 - InvestorPlace.com
Eased Geopolitical Tensions Have Little Effect on Interest Rates 12:16 p.m. Aug. 15, 2014 - TheStreet.com
Put Some of Your Accumulated Cash To Work 9:28 p.m. Aug. 14, 2014 - InvestorPlace.com
Biotech is the Best Buy in This Market 9:47 p.m. Aug. 13, 2014 - InvestorPlace.com
'Fast Money' Recap: Can You Trust This Rally? 5:00 a.m. Aug. 12, 2014 - TheStreet.com
Strength of the Junior Indices is Encouraging, But… 9:34 p.m. Aug. 11, 2014 - InvestorPlace.com
U.S. Stock Market in a Critical Position 9:59 p.m. Aug. 10, 2014 - InvestorPlace.com
12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha

Premier Biomedical Advances Technology via Partnerships 10:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 9:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 9:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 6:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 8:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 8:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 8:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 12:06 p.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 8:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 8:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 8:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 9:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 8:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 8:52 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...